EMR-Based Treatment for Neurological Disorders
Trial Summary
What is the purpose of this trial?
The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment for neurological disorders using EMR-based quality improvement and practice-based research?
The use of electronic medical records (EMRs) in neurology helps standardize patient data collection and supports quality improvement and research, which can lead to better care for conditions like memory disorders and epilepsy. By using structured documentation and decision support tools, EMRs can improve the management and outcomes of various neurological disorders.12345
Is EMR-based treatment for neurological disorders generally safe for humans?
How does the EMR-based treatment for neurological disorders differ from other treatments?
The EMR-based treatment for neurological disorders is unique because it uses electronic medical records to standardize patient data collection and support practice-based research, which helps improve the quality of care and tailor treatments to individual needs. This approach allows for more precise tracking of patient progress and facilitates the sharing of data across departments to enhance research and treatment strategies.124510
Eligibility Criteria
This trial is for individuals with neurological conditions like brain tumors, epilepsy, migraine, cognitive impairments due to mild injury or concussion, multiple sclerosis (MS), neuropathy, Parkinson's disease, restless legs syndrome and stroke. Participants must be eligible for the treatments being tested as per FDA approval or standard off-label use.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive subgroup based adaptive assignment of treatments for neurological disorders using the EMR
Follow-up
Participants are monitored for safety and effectiveness after treatment using outcomes data capture at the point of care
Treatment Details
Interventions
- Quality Improvement and Practice Based Research
Find a Clinic Near You
Who Is Running the Clinical Trial?
NorthShore University HealthSystem
Lead Sponsor
Endeavor Health
Lead Sponsor